Stereotactic body radiation therapy for metastasis to the adrenal glands

Kevin Shiue, Andrew Song, Bin S. Teh, Rodney J. Ellis, Min Yao, Nina A. Mayr, Zhibin Huang, Jason Sohn, Mitchell Machtay, Simon S. Lo

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


Many primary cancers can metastasize to the adrenal glands. Adrenalectomy via an open or laparoscopic approach is the current definitive treatment, but not all patients are eligible or wish to undergo surgery. There are only limited studies on the use of conventional radiation therapy for palliation of symptoms from adrenal metastasis. However, the advent of stereotactic body radiation therapy (SBRT) - also named stereotactic ablative radiotherapy for primary lung cancer, metastases to the lung, and metastases to the liver - have prompted some investigators to consider the use of SBRT for metastases to the adrenal glands. This review focuses on the emerging data on SBRT of metastasis to the adrenal glands, while also providing a brief discussion of the overall management of adrenal metastasis.

Original languageEnglish (US)
Pages (from-to)1613-1620
Number of pages8
JournalExpert Review of Anticancer Therapy
Issue number12
StatePublished - Dec 2012

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pharmacology (medical)


Dive into the research topics of 'Stereotactic body radiation therapy for metastasis to the adrenal glands'. Together they form a unique fingerprint.

Cite this